Unknown

Dataset Information

0

Fibronectin type III domain-containing 5 improves aging-related cardiac dysfunction in mice.


ABSTRACT: Aging is an important risk factor for cardiovascular diseases, and aging-related cardiac dysfunction serves as a major determinant of morbidity and mortality in elderly populations. Our previous study has identified fibronectin type III domain-containing 5 (FNDC5) and its cleaved form, irisin, as the cardioprotectant against doxorubicin-induced cardiomyopathy. Herein, aging or matched young mice were overexpressed with FNDC5 by adeno-associated virus serotype 9 (AAV9) vectors, or subcutaneously infused with irisin to uncover the role of FNDC5 in aging-related cardiac dysfunction. To verify the involvement of nucleotide-binding oligomerization domain-like receptor with a pyrin domain 3 (NLRP3) and AMP-activated protein kinase α (AMPKα), Nlrp3 or Ampkα2 global knockout mice were used. Besides, young mice were injected with AAV9-FNDC5 and maintained for 12 months to determine the preventive effect of FNDC5. Moreover, neonatal rat cardiomyocytes were stimulated with tumor necrosis factor-α (TNF-α) to examine the role of FNDC5 in vitro. We found that FNDC5 was downregulated in aging hearts. Cardiac-specific overexpression of FNDC5 or irisin infusion significantly suppressed NLRP3 inflammasome and cardiac inflammation, thereby attenuating aging-related cardiac remodeling and dysfunction. In addition, irisin treatment also inhibited cellular senescence in TNF-α-stimulated cardiomyocytes in vitro. Mechanistically, FNDC5 activated AMPKα through blocking the lysosomal degradation of glucagon-like peptide-1 receptor. More importantly, FNDC5 gene transfer in early life could delay the onset of cardiac dysfunction during aging process. We prove that FNDC5 improves aging-related cardiac dysfunction by activating AMPKα, and it might be a promising therapeutic target to support cardiovascular health in elderly populations.

SUBMITTER: Hu C 

PROVIDER: S-EPMC8920441 | biostudies-literature | 2022 Mar

REPOSITORIES: biostudies-literature

altmetric image

Publications

Fibronectin type III domain-containing 5 improves aging-related cardiac dysfunction in mice.

Hu Can C   Zhang Xin X   Hu Min M   Teng Teng T   Yuan Yu-Pei YP   Song Peng P   Kong Chun-Yan CY   Xu Si-Chi SC   Ma Zhen-Guo ZG   Tang Qi-Zhu QZ  

Aging cell 20220215 3


Aging is an important risk factor for cardiovascular diseases, and aging-related cardiac dysfunction serves as a major determinant of morbidity and mortality in elderly populations. Our previous study has identified fibronectin type III domain-containing 5 (FNDC5) and its cleaved form, irisin, as the cardioprotectant against doxorubicin-induced cardiomyopathy. Herein, aging or matched young mice were overexpressed with FNDC5 by adeno-associated virus serotype 9 (AAV9) vectors, or subcutaneously  ...[more]

Similar Datasets

| S-EPMC4827815 | biostudies-literature
| S-EPMC10741045 | biostudies-literature
| S-EPMC2583400 | biostudies-literature
| S-EPMC3234744 | biostudies-literature
| S-EPMC6481110 | biostudies-literature
| S-EPMC8379181 | biostudies-literature
| S-EPMC6201590 | biostudies-literature
| S-EPMC8906042 | biostudies-literature
| S-EPMC9750624 | biostudies-literature
| S-EPMC11567257 | biostudies-literature